Initial report of a phase I/II study of S-1 and irinotecan (IRIS) in combination with cetuximab in patients with wild-type RAS metastatic colorectal cancer

TY - JOUR

T1 - Initial report of a phase I/II study of S-1 and irinotecan (IRIS) in combination with cetuximab in patients with wild-type RAS metastatic colorectal cancer

AU - Oki, E.

AU - Samura, H.

AU - Okumura, H.

AU - Ohchi, T.

AU - Orita, H.

AU - Kobayashi, K.

AU - Kinjo, T.

AU - Mori, S.

AU - Touyama, T.

AU - Ohgaki, K.

AU - Kawanaka, H.

AU - Makiyama, A.

AU - Ureshino, N.

AU - Kotaka, M.

AU - Shimose, T.

AU - Saeki, H.

AU - Nishimaki, T.

AU - Baba, H.

AU - Maehara, Y.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081532244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081532244&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy281.040

DO - 10.1093/annonc/mdy281.040

M3 - Article

C2 - 32136293

SN - 0923-7534

VL - 29

SP - viii166

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -